85 related articles for article (PubMed ID: 15608421)
1. Nuclear factor-KappaB as a common target and activator of oncogenes in head and neck squamous cell carcinoma.
Chang AA; Van Waes C
Adv Otorhinolaryngol; 2005; 62():92-102. PubMed ID: 15608421
[TBL] [Abstract][Full Text] [Related]
2. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
Allen CT; Ricker JL; Chen Z; Van Waes C
Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
[TBL] [Abstract][Full Text] [Related]
4. Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells.
Macha MA; Matta A; Chauhan SS; Siu KW; Ralhan R
Carcinogenesis; 2011 Mar; 32(3):368-80. PubMed ID: 21177768
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
[TBL] [Abstract][Full Text] [Related]
6. Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
Janus SC; Weurtz B; Ondrey FG
Laryngoscope; 2007 Aug; 117(8):1381-8. PubMed ID: 17607147
[TBL] [Abstract][Full Text] [Related]
7. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
[TBL] [Abstract][Full Text] [Related]
8. NF-Kappa-B downregulation strategies in head and neck cancer treatment.
Patel A; Miller L; Ahmed K; Ondrey F
Otolaryngol Head Neck Surg; 2004 Sep; 131(3):288-95. PubMed ID: 15365549
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
Ferris RL; Grandis JR
Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953
[No Abstract] [Full Text] [Related]
10. [Expression of the transcription factors NF-kappaB and HIF-1 in squamous cell carcinomas of the head and neck: association with disease prognosis].
Choĭnzonov EL; Spirina LV; Kondrakova IV; Shishkin DA; Chizhevskaia SIu
Vopr Onkol; 2013; 59(5):575-9. PubMed ID: 24260883
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.
Sasaki N; Morisaki T; Hashizume K; Yao T; Tsuneyoshi M; Noshiro H; Nakamura K; Yamanaka T; Uchiyama A; Tanaka M; Katano M
Clin Cancer Res; 2001 Dec; 7(12):4136-42. PubMed ID: 11751513
[TBL] [Abstract][Full Text] [Related]
12. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
13. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
14. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
Bindhu OS; Ramadas K; Sebastian P; Pillai MR
Head Neck; 2006 Oct; 28(10):916-25. PubMed ID: 16823875
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
Waitzberg AF; Nonogaki S; Nishimoto IN; Kowalski LP; Miguel RE; Brentani RR; Brentani MM
Cancer Detect Prev; 2004; 28(3):178-86. PubMed ID: 15225897
[TBL] [Abstract][Full Text] [Related]
16. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
Koukourakis MI; Giatromanolaki A; Fountzilas G; Sivridis E; Gatter KC; Harris AL
Clin Cancer Res; 2000 Feb; 6(2):381-9. PubMed ID: 10690514
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]